Abstract: The invention is directed to a guidewire having a distal section with multiple distally tapered core segments with at least two contiguous distally tapering core segments in which the most distal tapered core segment preferably has a greater degree of taper than the proximally contiguous tapered core segment. The invention is also directed to an elongated intracorporeal device, preferably a guidewire or section thereof, that has a core member or the like with a plurality of contiguous tapered segments having taper angles that are configured to produce a linear change in stiffness over a longitudinal section of the device. The device may also have a core section with a continuously changing taper angle to produce a curvilinear profile that preferably is configured to produce a linear change in stiffness of the core over a longitudinal section of the device.
Type:
Grant
Filed:
June 1, 2011
Date of Patent:
November 13, 2012
Assignee:
Advanced Cardiovascular Systems, Inc.
Inventors:
Wayne E. Cornish, John F. Schreiner, James M. Jacobs, Marc M. Jalisi, Mark T. Richardson, Kent C. B. Stalker, Olin J. Palmer
Abstract: A segmented polyurethane and an amphiphilic random or block copolymer are disclosed. The segmented polyurethane and the amphiphilic random or block copolymer can be used for fabricating a coating for an implantable medical device such as a stent.
Type:
Grant
Filed:
December 24, 2003
Date of Patent:
November 13, 2012
Assignee:
Advanced Cardiovascular Systems, Inc.
Inventors:
Thierry Glauser, Connie S. Kwok, Charles D. Claude, Eugene T. Michal, Yiwen Tang, Irina Astafieva, John Whatley, Stephen D. Pacetti, Ashok Shah
Abstract: A locking component for locking a medical device onto a guide wire. Such medical devices include, for example, an embolic filter assembly used to capture embolic material that may be created and released into a patient's vasculature during a stenting or angioplasty procedure. The embolic filter assembly tracks along the guide wire, and is delivered to a treatment site where it is locked in place and deployed. The locking component enables the filter assembly to lock onto any standard guide wire, and does not require a modified guide wire that has a specially-designed fitting or stop to accomplish the locking function.
Type:
Grant
Filed:
February 25, 2010
Date of Patent:
November 13, 2012
Assignee:
Advanced Cardiovascular Systems, Inc.
Inventors:
Douglas H. Gesswein, David K. Wrolstad, David H. Burkett, Robert C. Esselstein, Kathern J. Lind, Pablito Buan, Robert C. Hazelden, Thomas Tokarchik, III, Ryan Grandfield, Aaron Baldwin, Wayne E. Cornish, Philip Yip
Abstract: A method of crimping a stent on a balloon of a catheter assembly is provided. A polymeric stent is disposed over a balloon in an inflated configuration. The stent is crimped over the inflated balloon to a reduced crimped configuration so that the stent is secured onto the balloon. The balloon wall membrane is wedged or pinched between the strut elements of the stent for increasing the retention of the stent on the balloon.
Type:
Application
Filed:
July 17, 2012
Publication date:
November 8, 2012
Applicant:
Advanced Cardiovascular Systems, Inc.
Inventors:
Bin Huang, David C. Gale, Daniel Castro
Abstract: Bioscaffoldings formed of hydrogels that are crosslinked in situ in an infarcted region of the heart (myocardium) by a Michael's addition reaction or by a disulfide bond formed by an oxidative process are described. Each of the bioscaffoldings described includes hyaluronan as one of the hydrogel components and the other component is selected from collagen, collagen-laminin, poly-l-lysine, and fibrin. The bioscaffolding may further include an alginate component. The bioscaffoldings may have biofunctional groups such as angiogenic factors and stem cell homing factors bound to the collagen, collagen-laminin, poly-l-lysine, or fibrinogen hydrogel component. In particular, the biofunctional groups may be PR11, PR39, VEGF, bFGF, a polyarginine/DNA plasmid complex, or a DNA/polyethyleneimine (PEI) complex. Additionally, the hydrogel components may be injected into the infarct region along with stem cells and microspheres containing stem cell homing factors.
Abstract: An intravascular stent is formed by utilizing the process of metal injection molding (MIM) applied to metal powder, ceramic powder and ceramic metal composite powder. The devices may have longitudinal/circumferential channels and/or depots molded into the tubing thereof to enable such devices to act as a functional drug delivery vehicle having adequate drug reservoir capability.
Abstract: A stent for delivery of a therapeutic agent is disclosed. The stent includes a polymer coating for reducing the rate of release of the therapeutic agent. The polymer has a crystalline structure wherein the polymer is capable of significantly maintaining the crystalline lattice structure while the therapeutic agent is released from the stent such that the aqueous environment to which the stent is exposed subsequent to the implantation of the stent does not significantly convert the crystalline lattice structure of the polymer to an amorphous structure.
Abstract: Hyaluronic acid (HA) conjugates or crosslinked HAs compositions for coating an implantable device are provided. The implantable device can be used for treating a disorder such as atherosclerosis, thrombosis, restenosis, high cholesterol, hemorrhage, vascular dissection or perforation, vascular aneurysm, vulnerable plaque, chronic total occlusion, claudication, anastomotic proliferation for vein and artificial grafts, bile duct obstruction, ureter obstruction, tumor obstruction, and combinations thereof.
Type:
Grant
Filed:
April 30, 2004
Date of Patent:
October 23, 2012
Assignee:
Advanced Cardiovascular Systems, Inc.
Inventors:
Syed Faiyaz Ahmed Hossainy, Eugene Michal, Thierry Glauser, Connie Kwok, Stephen Dirk Pacetti
Abstract: An expandable stent is implanted in a body lumen, such as a coronary artery, peripheral artery, or other body lumen for treating an area of vulnerable plaque. The invention provides for a an intravascular stent having a plurality of cylindrical rings connected by undulating links. The stent has a high degree of flexibility in the longitudinal direction, yet has adequate vessel wall coverage and radial strength sufficient to hold open an artery or other body lumen. A central section is positioned between distal and proximal sections and is aligned with the area of vulnerable plaque to enhance growth of endothelial cells over the fibrous cap of the vulnerable plaque to reinforce the area and reduce the likelihood of rupture.
Abstract: A system, nozzle assembly, and method for coating a stent with a solvent and polymer are provided. The polymer can include a therapeutic substance or a drug. The polymer and solvent can be discharged from separate tubes disposed within another tube carrying moving air. The polymer and the solvent mix together when they are discharged and are atomized by the air. The ends of the tubes can be concentric with each other. The ends of the tubes can also be positioned relative to each other to prevent accumulation of polymer at the ends of the tubes.
Abstract: A nozzle for use in a coating apparatus for the application of a coating substance to a stent is provided. Method for coating a stent can include discharging a coating composition out from a needle of a nozzle assembly, and atomizing the coating composition as the coating composition is discharged. The needle can be positioned in a chamber of the nozzle assembly, and gas can be introduced into the chamber for atomizing the coating composition.
Type:
Grant
Filed:
January 18, 2008
Date of Patent:
October 9, 2012
Assignee:
Advanced Cardiovascular Systems, Inc.
Inventors:
Yung-Ming Chen, Stephen James Guittard, Joe Broeckert
Abstract: A method for fabricating a coating for an implantable medical device is provided comprising applying a first polymer on at least a portion of the device to form a first layer of the coating and applying a second polymer on at least a portion of the first layer to form a second layer of the coating. The second polymer has a lower degree of hydration than the first polymer.
Type:
Grant
Filed:
January 18, 2008
Date of Patent:
October 2, 2012
Assignee:
Advanced Cardiovascular Systems, Inc.
Inventors:
Stephen D. Pacetti, Syed F. A. Hossainy, Yiwen Tang, Andrew C. Tung, Thierry Glauser
Abstract: A method of delivering an arteriogenic factor. The factor is delivered in a medically effective manner to structurally enlarge blood vessel. A distal portion of a catheter can be advanced to an existing blood vessel to deliver the arteriogenic factor.
Abstract: Methods and compositions for treating post-myocardial infarction damage are herein disclosed. In some embodiments, a carrier with a treatment agent may be fabricated. The carrier can be formulated from a bioerodable, sustained-release substance. The resultant loaded carrier may then be suspended in at least one component of a two-component matrix system for simultaneous delivery to a post-myocardial infarction treatment area.
Type:
Application
Filed:
May 25, 2012
Publication date:
September 20, 2012
Applicant:
Advanced Cardiovascular Systems, Inc.
Inventors:
Eugene Michal, Shubhayu Basu, Hai-Chien Kuo
Abstract: Stents fabricated from hydrolytically degradable polymers with accelerated degradation rates and methods of fabricating stents with accelerated degradation rates are disclosed.
Type:
Grant
Filed:
August 31, 2010
Date of Patent:
September 18, 2012
Assignee:
Advanced Cardiovascular Systems, Inc.
Inventors:
David C. Gale, Bin Huang, Vincent Gueriguian, Syed Faiyaz Ahmed Hossainy